Targeting educational therapy for type 2 diabetes: identification of predictors of therapeutic success

Patient education is a key component of diabetes care. Limits in resources often prevent the participation of many patients with type 2 diabetes to structured education programs. The identification of predictors of response to group education could help in selecting those patients in whom the interv...

Full description

Saved in:
Bibliographic Details
Published in:Acta diabetologica 2013-06, Vol.50 (3), p.309-317
Main Authors: da Vico, Letizia, Monami, Matteo, Biffi, Barbara, Lamanna, Caterina, Martelli, Chiara, Marchionni, Niccolò, Mannucci, Edoardo
Format: Article
Language:English
Subjects:
Aged
Body Mass Index
Cholesterol, Dietary - administration & dosage
Counseling - methods
Counseling - organization & administration
Diabetes
Diabetes Mellitus, Type 2 - diet therapy
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - psychology
Dietary Proteins - administration & dosage
Drug therapy
Feeding Behavior
Female
Follow-Up Studies
Glycated Hemoglobin A - metabolism
Health education
Humans
Hypoglycemic Agents - therapeutic use
Internal Medicine
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Original Article
Patient Education as Topic - methods
Patient Education as Topic - organization & administration
Predictive Value of Tests
Program Evaluation
Prospective Studies
Self Care - methods
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patient education is a key component of diabetes care. Limits in resources often prevent the participation of many patients with type 2 diabetes to structured education programs. The identification of predictors of response to group education could help in selecting those patients in whom the intervention is more cost-effective. A structured interactive group program was proposed to a consecutive series of 150 type 2 diabetes patients, who were then followed prospectively in 24 months, with measurements of HbA1c, BMI, quality of life, eating habits. For comparison, another consecutive series of 113 patients who had received no intervention was also observed for 12 months. A significant reduction in HbA1c was observed in the intervention group at 12 and 24 months (from 7.5 ± 1.4 to 6.9 ± 1.2 and 6.6 ± 1.1% at 12 and 24 months, respectively, both P  
ISSN:0940-5429
1432-5233
DOI:10.1007/s00592-012-0377-2